BeyondSpring Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.19
- Today's High:
- $1.28
- Open Price:
- $1.25
- 52W Low:
- $0.542
- 52W High:
- $3.45
- Prev. Close:
- $1.25
- Volume:
- 88400
Company Statistics
- Market Cap.:
- $48.30 million
- Book Value:
- 0.208
- Revenue TTM:
- $1.35 million
- Operating Margin TTM:
- -3674.98%
- Gross Profit TTM:
- $1.35 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -42.42%
- Return on Equity TTM:
- -146.8%
Company Profile
BeyondSpring Inc had its IPO on 2017-03-09 under the ticker symbol BYSI.
The company operates in the Healthcare sector and Biotechnology industry. BeyondSpring Inc has a staff strength of 103 employees.
Stock update
Shares of BeyondSpring Inc opened at $1.25 at the start of the last trading session i.e. 2023-03-19.
The stocks traded within a range of $1.19 - $1.28, and closed at $1.24.
This is a -0.8% slip from the previous day's closing price.
A total volume of 88,400 shares were traded at the close of the day’s session.
In the last one week, shares of BeyondSpring Inc have slipped by -23.46%.
BeyondSpring Inc's Key Ratios
BeyondSpring Inc has a market cap of $48.30 million, indicating a price to book ratio of 1.6777 and a price to sales ratio of 62.2401.
In the last 12-months BeyondSpring Inc’s revenue was $1.35 million with a gross profit of $1.35 million and an EBITDA of $-49594500. The EBITDA ratio measures BeyondSpring Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, BeyondSpring Inc’s operating margin was -3674.98% while its return on assets stood at -42.42% with a return of equity of -146.8%.
In Q4, BeyondSpring Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
BeyondSpring Inc’s PE and PEG Ratio
- Forward PE
- 10.5374
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-1.21 per share while it has a forward price to earnings multiple of 10.5374 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BeyondSpring Inc’s profitability.
BeyondSpring Inc stock is trading at a EV to sales ratio of 5.269 and a EV to EBITDA ratio of 0.3725. Its price to sales ratio in the trailing 12-months stood at 62.2401.
BeyondSpring Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $63.77 million
- Total Liabilities
- $11.11 million
- Operating Cash Flow
- $-4729000.00
- Capital Expenditure
- $2.81 million
- Dividend Payout Ratio
- 0%
BeyondSpring Inc ended 2023 with $63.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $63.77 million while shareholder equity stood at $8.11 million.
BeyondSpring Inc ended 2023 with $0 in deferred long-term liabilities, $11.11 million in other current liabilities, in common stock, $-360486000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $30.74 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
BeyondSpring Inc’s total current assets stands at $55.73 million while long-term investments were $0 and short-term investments were $21.20 million. Its net receivables were $0 compared to accounts payable of $1.16 million and inventory worth $0.
In 2023, BeyondSpring Inc's operating cash flow was $-4729000.00 while its capital expenditure stood at $2.81 million.
Comparatively, BeyondSpring Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $1.24
- 52-Week High
- $3.45
- 52-Week Low
- $0.542
- Analyst Target Price
- $1
BeyondSpring Inc stock is currently trading at $1.24 per share. It touched a 52-week high of $3.45 and a 52-week low of $3.45. Analysts tracking the stock have a 12-month average target price of $1.
Its 50-day moving average was $2.1 and 200-day moving average was $1.46 The short ratio stood at 9.42 indicating a short percent outstanding of 0%.
Around 5128.5% of the company’s stock are held by insiders while 1549.3% are held by institutions.
Frequently Asked Questions About BeyondSpring Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company’s lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.